Jim Cramer Discusses Big Humana (HUM) Business

We recently published Jim Cramer Said Allbirds Management Are “Jokers” & Discussed These 18 Stocks. Humana Inc. (NYSE:HUM) is one of the stocks discussed by Jim Cramer.

Humana Inc. (NYSE:HUM) is one of the largest health insurance providers in America. Its shares are down by 31% over the past year and by 26% year-to-date. Barclays discussed the firm’s stock on February 25th as it significantly cut the share price target to $176 from $245 and maintained a Buy rating on the shares. The bank commented that Humana Inc. (NYSE:HUM)’s remarks of Medicare Advantage margins doubling should be viewed with caution. On the 6th, the Trump Administration made a major announcement as it increased Medicare Advantage payments by 2.48% to more than $13 billion in 2027. The announcement led to movement in health insurer stocks, with Humana Inc. (NYSE:HUM)’s shares gaining 11% between the 2nd and the 7th. Naturally, as the announcement was made, Cramer also discussed the health insurance company and remarked that it relied quite a bit on Medicare Advantage:

“Humana and CVS, Humana’s got a big Medicare Advantage business and that stock’s doing quite well”

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.